The Chief Experience Officer – An Emerging & Critical Role

This paper explores the impact and influence of the growing role of Chief Experience Officer (CXO) . It is a role that encompasses and leads a broad portfolio of resources and services fundamental to the patient and family experience – from advocacy to service and, in some cases, broadening to lead or significantly influence people, quality and safety issues. The paper asserts that if an organization wishes to lead in the patient and family experience, the role of CXO or Senior Patient Experience Leader must be part of an organization’s senior leadership and is central to a broader commitment on patient experience excellence.
Related content
-
Culture & Leadership | Innovation & Technology | Staff & Provider Engagement
Human-Centered Leader Rounding: Using Generational Insights and Personalization
Explore how healthcare leaders can design and adapt their rounding processes to cater to different patient and employee generations, combining generational data with a personalized approach that is specific to the individual. The discussion will focus on personalized care, communication preferences, and bridging generational gaps in expectations through a human-centric approach that prioritizes empathy and
Learn more -
Culture & Leadership | Infrastructure & Governance
ED Patient Loyalty Scores Nearly Double Through an Innovative Patient Navigator Role
2pm ET / 1pm CT / 12pm MT / 11am PT – The ED clinical patient navigator (PN) role addresses experience gaps related to wait times, communication, teamwork, and personalized care during visits. By creating a patient experience value stream map, we identified the need for the PN role, focusing on patients at risk for
Learn more -
Culture & Leadership
Contrasting Patients’ and Healthcare Professionals’ Experience in Hematological Cancer Care Pathway : A Narrative Study
Hematological cancers represent 10% of cancers diagnosed in Canada. Treatments involve complex care pathways and various modalities as well as the management and monitoring of multiple side effects. There is limited understanding of these pathways from the perspectives of the people living with cancer (PLC) and the healthcare professional (HCP). The aim of this article
Learn more